echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Leadstar Bio's "International Invention Patent for Non-invasive Monitoring of Tumor Progress" was authorized by the U.S. Patent Office

    Leadstar Bio's "International Invention Patent for Non-invasive Monitoring of Tumor Progress" was authorized by the U.S. Patent Office

    • Last Update: 2022-02-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    SHANGHAI, Nov.


    The technology has been developed and completed since 2015.


    This invention patent develops a ctDNA-based MRD assessment and dynamic monitoring method for pan-cancer species.


    At present, the clinical application of MRD is still in its infancy.


    Leadstar independently developed this MRD assessment and dynamic monitoring method based on ctDNA monitoring, which has clinical application value such as minimal residual disease assessment, tumor progression monitoring, and drug efficacy monitoring


    The international patent of Linkstar ctDNA monitoring tumor load in blood provides a large amount of multi-cancer type and strong evidence support for the clinical application of ctDNA-based MRD evaluation method, helping clinicians to provide more individualized and precise treatment for patients, enabling China The production and research capabilities in this field have reached the international leading level


    Source: Leadstar Bio

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.